| 000 | 01493 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250514200358.0 | ||
| 264 | 0 | _c20041106 | |
| 008 | 200411s 0 0 eng d | ||
| 022 | _a0918-2918 | ||
| 024 | 7 |
_a10.2169/internalmedicine.43.540 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDingli, David | |
| 245 | 0 | 0 |
_aMyelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment. _h[electronic resource] |
| 260 |
_bInternal medicine (Tokyo, Japan) _cJul 2004 |
||
| 300 |
_a540-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBiopsy, Needle |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xmethods |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xmethods |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrimary Myelofibrosis _xcomplications |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTransplantation, Homologous |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aMesa, Ruben A | |
| 700 | 1 | _aTefferi, Ayalew | |
| 773 | 0 |
_tInternal medicine (Tokyo, Japan) _gvol. 43 _gno. 7 _gp. 540-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2169/internalmedicine.43.540 _zAvailable from publisher's website |
| 999 |
_c15032590 _d15032590 |
||